News

Symptoms of schizoaffective disorder are complex and without treatment they are disabling. Janssen Scientific Affairs director of Clinical Development Dong-Jing Fu said: "Schizoaffective disorder is a difficult-to-treat disease.

SSc is a rare multisystem, autoimmune disease that results in the overproduction and abnormal growth of collagen, which causes fibrosis of the skin and internal organs. dcSSc is

The company is focused on the development and commercialization of a once-daily, oral medication to treat liver diseases and cholesterol gallstones. The single center, randomized, double blind, placebo

The company said that the new delivery approaches seek to target the desired tissue more effectively. The deal builds on an existing collaboration between the two firms, and

JCRI composes part of USPI’s new 45,000 square-foot Canady Innovation Center (CIC), which houses a cross-functional team of global scientists, physicians, clinicians, healthcare professionals and engineers who collaborate

The collaboration, which will leverage the strengths of both organizations, is aimed at accelerating the development of transformational new therapies for these underserved patients. The biobank at CHOP’s

ONL101 is a first-in-class small molecule peptide currently under development to protect photoreceptors in retinal detachment, a condition for which the product has been granted orphan disease designation.

Vasostrict is the first and only vasopressin injection, USP, product with an NDA approved by the US FDA and it is indicated to increase blood pressure in adults

ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor with a kinase selectivity profile and multiple mechanisms of action. This is the company’s second approval to start a Phase